Wednesday, November 09, 2022 9:38:54 AM
According to their last 10Q their debt was very high.
According to their last 10Q they took in hundreds of thousands of convertible notes.
According to all their filings it would seem as if they operate at a loss as if it was customary to operate at a loss.
Companies can operate at a loss when their business has a turnaround strategy like tech companies, life sciences, but definately not assisted living centers or non acute residences. It as if the management at Clearday have no clue as to what they are doing from an operational standpoint and they definately have no clue what all those convertible notes are going to do to the stock.
When those notes come due they either have to repay with cash which they have zero or issue MILLIONS of shares at a real big discount to market and that means those note holders are going to sell the stock and drive the price down so far that it will be a complete disaster. This is a short if there ever was one but because of the no volume you can't even make money in what everyone knows will happen to the stock.
Recent CLRD News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/22/2024 09:35:36 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/15/2024 10:19:49 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/09/2024 10:00:42 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/08/2024 09:45:26 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/28/2023 09:15:22 PM
- Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend] • Edgar (US Regulatory) • 10/31/2023 08:42:23 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/17/2023 08:30:35 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 09/14/2023 10:06:27 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/29/2023 03:00:11 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 08/14/2023 08:31:18 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 07/18/2023 08:47:16 PM
FEATURED NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM